Sterling Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Buy
170,257
+138,960
+444% +$8.1M 0.2% 94
2025
Q4
$1.69M Buy
31,297
+8,951
+40% +$431K 0.03% 453
2025
Q3
$1.01M Sell
22,346
-72,134
-76% -$3.37M 0.01% 623
2025
Q2
$4.37M Buy
94,480
+27,610
+41% +$1.36M 0.06% 218
2025
Q1
$4.08M Sell
66,870
-8,504
-11% -$496K 0.06% 205
2024
Q4
$4.26M Buy
75,374
+18,528
+33% +$1.04M 0.06% 253
2024
Q3
$2.94M Buy
+56,846
New +$2.67M 0.04% 306
2019
Q3
$67.1M Buy
1,323,691
+3,197
+0.2% +$150K 0.64% 58
2019
Q2
$59.9M Buy
1,320,494
+107,287
+9% +$5M 0.58% 68
2019
Q1
$57.9M Buy
1,213,207
+160,316
+15% +$7.99M 0.57% 70
2018
Q4
$54.7M Sell
1,052,891
-60,592
-5% -$3.26M 0.59% 64
2018
Q3
$69.1M Sell
1,113,483
-11,197
-1% -$664K 0.62% 61
2018
Q2
$62.2M Buy
1,124,680
+161,117
+17% +$8.7M 0.58% 64
2018
Q1
$60.9M Sell
963,563
-3,041
-0.3% -$196K 0.57% 64
2017
Q4
$59.2M Sell
966,604
-14,307
-1% -$895K 0.54% 72
2017
Q3
$62.5M Buy
980,911
+24,629
+3% +$1.44M 0.59% 65
2017
Q2
$53.3M Buy
956,282
+25,593
+3% +$1.39M 0.51% 75
2017
Q1
$50.6M Sell
930,689
-80,535
-8% -$4.42M 0.48% 74
2016
Q4
$59.1M Sell
1,011,224
-1,974
-0.2% -$108K 0.53% 71
2016
Q3
$54.6M Buy
1,013,198
+997,164
+6,219% +$64.1M 0.5% 76
2016
Q2
$1.18M Sell
16,034
-145
-0.9% -$10.2K 0.01% 493
2016
Q1
$1.03M Sell
16,179
-11,666
-42% -$736K 0.01% 514
2015
Q4
$1.92M Buy
27,845
+13,888
+100% +$918K 0.02% 390
2015
Q3
$826K Sell
13,957
-8,408
-38% -$533K 0.01% 578
2015
Q2
$1.49M Buy
22,365
+282
+1% +$18.6K 0.01% 363
2015
Q1
$1.42M Buy
22,083
+2,233
+11% +$140K 0.01% 377
2014
Q4
$1.17M Buy
19,850
+706
+4% +$39.8K 0.01% 621
2014
Q3
$980K Buy
19,144
+5,530
+41% +$276K 0.01% 616
2014
Q2
$660K Sell
13,614
-3,275
-19% -$161K 0.01% 677
2014
Q1
$877K Buy
16,889
+5,138
+44% +$273K 0.01% 634
2013
Q4
$625K Buy
11,751
+3,327
+39% +$169K 0.01% 501
2013
Q3
$390K Buy
8,424
+165
+2% +$7.24K ﹤0.01% 481
2013
Q2
$369K Buy
+8,259
New +$359K ﹤0.01% 355

Other funds holding BMY